China debuts quantum-embedded GNN for drug discovery
Chinese team unveils quantum-embedded GNN with edge encoding to predict drug properties more accurately on noisy quantum hardware.
According to Science and Technology Daily, Chinese researchers have reported a breakthrough in quantum drug discovery using edge encoding. Origin Quantum, USTC, and the Hefei AI Institute built a quantum-embedded graph neural network (GNN) to predict drug-molecule properties.
In drug development, graph neural networks model molecules as atoms and bonds. Classical and some quantum approaches handle atoms well but struggle with bonds. The gap limits accuracy and screening speed.
The team from China introduced quantum edge and node embeddings to process bonds and atoms simultaneously at the quantum level. The quantum-embedded GNN unifies both signals in one pass. Results show sharper predictions for the properties of candidate drugs.
Validation on the Origin Wukong quantum computer indicates stable performance despite today’s noisy hardware. Benchmarking suggests efficiency gains for molecular screening pipelines. Researchers say the approach is production-oriented as devices scale.
Findings appear in the Journal of Chemical Information and Modelling. Collaboration highlights China’s push to integrate quantum computing with biopharmaceutical research and development. More exhaustive testing on larger qubit counts is anticipated.
Would you like to learn more about AI, tech, and digital diplomacy? If so, ask our Diplo chatbot!
